Improving US Cannabis Laws Through Cohesion and Health Focus

The National Academies of Sciences, Engineering, and Medicine (NASEM) recently released a pivotal report urging the United States federal government to adopt stronger regulatory frameworks for cannabis, prioritizing public health over profit. This comprehensive study emphasizes the need for cohesion among the numerous state-legal models of cannabis, which currently vary significantly across the nation.

Learning from Other Nations

The report highlights successful cannabis regulatory strategies employed by countries like Canada and Uruguay that adopt a public health-first perspective in their legalization processes. These nations have crafted policies that enforce stricter oversight of cannabis products, focusing on minimizing public health risks rather than maximizing revenues through taxation and sales.

The US, in contrast, has largely prioritized revenue generation, which can undermine public health protections. As the report points out, the current cannabis policy landscape in the US lacks a unified strategy, making it difficult to effectively prevent harmful use across state lines.

Addressing Hemp Regulation Loopholes

One significant area of concern identified in the report relates to the 2018 Farm Bill’s vague definition of hemp, which has resulted in an unregulated market for semi-synthetic cannabinoids such as delta-8 THC. This has led to potential health risks that require immediate federal intervention.

“Existing state cannabis policies were developed without a public health strategy. State-to-state variations in regulations limit public health efforts to prevent harmful use.”

The Committee’s Recommendations

To promote a more cohesive and health-focused cannabis policy, the report outlines a series of recommendations which resonate with the regulatory frameworks adopted by other countries. These include:

• Clarifying Hemp Definitions: Congress should refine the definition of “hemp” to clarify that no form of tetrahydrocannabinol or semi-synthetic cannabinoid derived from hemp is exempt from the Controlled Substances Act.
• Public Health Research: The Centers for Disease Control and Prevention (CDC) should conduct research focused on public health measures for states with legalized cannabis, influencing regulations regarding advertising, age restrictions, and retail operations.
• Establishing a Surveillance System: A comprehensive surveillance system should be created to monitor cannabis cultivation, sales, usage patterns, and health impacts, enabling timely data-driven policy adjustments.
• Quality Control Standards: States should adopt stringent product quality and safety standards as established by the U.S. Pharmacopeia to ensure consumer safety.
• Retail Staff Training: Training and certifying retail staff on cannabis effects and responsible sales practices should be mandatory to prevent harm and promote public safety.
• Targeted Public Health Campaigns: Public health campaigns directed at vulnerable populations are essential to disseminate knowledge about cannabis risks and safe usage practices.
• Research Support for ONDCP: Removing restrictions on the Office of National Drug Control Policy (ONDCP) will foster a fruitful research environment regarding the impacts of cannabis legalization.
• Data Reporting and Community Engagement: Jurisdictions should routinely gather and report data on cannabis enforcement, while policies related to social equity must actively involve affected communities.
• Cleansing Criminal Records: Automatic expungement of records for low-level cannabis offenses is necessary upon legalization, promoting equity and reducing stigma.
• Health Impact Research Agenda: A comprehensive research agenda is crucial to assess health outcomes related to different cannabis regulatory approaches and the effects of emerging cannabinoids.

Steven Teutsch, chair of the committee and senior fellow at the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California, stressed the urgency of the situation, stating, “Our report shows that cannabis policy often focuses on regulating sales and revenue first, and protecting public health second.”

Conclusion: A Call for Action

As cannabis legalization continues to evolve across the United States, a unified approach that prioritizes public health is essential for effectively managing its societal impacts. By learning from the regulatory successes of Canada and Uruguay, the US has the opportunity to develop a robust cannabis policy framework that mitigates risks while respecting the rights of consumers. Federal intervention and coordinated public health strategies are necessary steps to ensure that the health and safety of citizens remain at the forefront of cannabis legislation.